Abstract:Abstract Background Vascular endothelial cell alignment in the direction of flow is an adaptive response that protects against aortic diseases such as atherosclerosis. The RhoGTPases are known to regulate this alignment. We have shown previously that ARHGAP18 in endothelial cells is a negative regulator of RhoC and its expression is essential in flow-mediated alignment. Depletion of ARHGAP18 inhibits alignment and results in the induction of a pro-inflammatory phenotype. In embryogenesis, ARHGAP18 was identified as a downstream effector of the Yes-associated protein, YAP, which regulates cell shape and size. Methods We have used siRNA technology to deplete either ARHGAP18 or YAP in human endothelial cells. The in vitro studies were performed under athero-protective, laminar flow conditions. The analysis of YAP activity was also investigated, using high performance confocal imaging, in our ARHGAP18 knockout mutant mice. Results We show here that loss of ARHGAP18, although decreasing the expression of YAP results in its nuclear localisation consistent with activation. We further show that depletion of YAP itself results in its activation as defined by an in increase in its nuclear localisation and an increase in the YAP target gene, CyR61. Depletion of YAP, similar to that observed for ARHGAP18 depletion, results in loss of endothelial cell alignment under high shear stress mediated flow and also in the activation of NFkB, as determined by p65 nuclear localisation. In contrast, ARHGAP18 overexpression results in upregulation of YAP, its phosphorylation, and a decrease in the YAP target gene Cyr61, consistent with YAP inactivation. Finally, in ARHGAP18 deleted mice, in regions where there is a loss of endothelial cell alignment, a situation associated with a priming of the cells to a pro-inflammatory phenotype, YAP shows nuclear localisation. Conclusion Our results show that YAP is downstream of ARHGAP18 in mature endothelial cells and that this pathway is involved in the athero-protective alignment of endothelial cells under laminar shear stress. ARHGAP18 depletion leads to a disruption of the junctions as seen by loss of VE-Cadherin localisation to these regions and a concomitant localisation of YAP to the nucleus.

ARHGAP12 suppresses F-actin assembly to control epithelial tight junction mechanics and paracellular leak pathway permeability

ARHGAP18-ezrin functions as an autoregulatory module for RhoA in the assembly of distinct actin-based structures

AIP1 Functions As Arf6-GAP to Negatively Regulate TLR4 Signaling.

Neuronal Wiskott-Aldrich Syndrome Protein Regulates Tgf-Beta 1-Mediated Lung Vascular Permeability

The Rho effector ARHGAP18 coordinates a Hippo pathway feedback loop through YAP and Merlin to regulate the cytoskeleton and epithelial cell polarity.

Anillin tunes contractility and regulates barrier function during Rho flare-mediated tight junction remodeling

The RhoGAP ARHGAP32 interacts with desmoplakin, and is required for desmosomal organization and assembly

Arp2/3-Branched Actin Maintains an Active Pool of GTP-RhoA and Controls RhoA Abundance.

Arp2/3-Branched Actin Maintains an Active Pool of GTP-RhoA and Controls RhoA Abundance

SHP2 Protects Endothelial Cell Barrier Through Suppressing VE-cadherin Internalization Regulated by MET-ARF1

Asap regulates cellular protrusions via dArf6-dependent actin regulatory pathway

ASPP2 Links the Apical Lateral Polarity Complex to the Regulation of YAP Activity in Epithelial Cells

Mlck-Dependent Exchange And Actin Binding Region-Dependent Anchoring Of Zo-1 Regulate Tight Junction Barrier Function

YAP and the RhoC regulator ARHGAP18, are required to mediate flow-dependent endothelial cell alignment

A complex of ZO-1 and the BAR-domain protein TOCA-1 regulates actin assembly at the tight junction

Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure

ARHGAP17 inhibits pathological cyclic strain-induced apoptosis in human Periodontal Ligament Fibroblasts via Rac1/Cdc42.

Neogenin recruitment of the WAVE regulatory complex maintains adherens junction stability and tension

PATJ inhibits histone deacetylase 7 to control tight junction formation and cell polarity

ARRDC5 cooperates with ACAP4 to regulate ARF6 activity at the cell membrane (964.1)

Human junction adhesion molecule regulates tight junction resealing in epithelia